MBI Named Finalist for Best R&D Pipeline, Best New Biological Product (Biopesticide) and Best Industry Collaboration Categories
DAVIS, Calif., Sept. 25, 2018 – Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, has been nominated as a finalist for the 2018 Agrow Awards in the categories of Best R&D Pipeline, Best New Biological Product (Biopesticide) and Best Industry Collaboration (for two separate collaborations).
MBI is a finalist for the “Best New Biopesticide” category via their Venerate Bioinsecticide, for the “Best R&D Pipeline” which include MBI’s bioherbicides and a biofumigant, “Best Industry Collaboration” in two separate products – one with Evogene for insecticidal protein discovery and one with Groundwork BioAg for an all-biological, broad spectrum seed treatment.
“On behalf of everyone at MBI, I would like to thank the Agrow Awards team for their recognition and continued support in advancing awareness about biopesticides and their important role in agriculture,” said Pam Marrone, MBI’s Founder and Chief Executive Officer. “Our place on the shortlist in three categories, including two industry collaborations, is a true testament to our success – bringing new agricultural innovations to market that help growers protect and improve their crop production.”
The prestigious Agrow Awards, presented by Agrow, a leading information provider for the global crop protection industry, features 15 categories in areas such as formulation, innovation, collaboration, marketing, business strategy and corporate responsibility. Winners are judged by an independent panel of industry experts. To be eligible for the awards, products were required to be formulated in a way that is acceptable to users and distributors, while also providing the ability to forge a path in a market dominated by synthetic chemicals.
MBI received High Commendation for its R&D pipeline at the 2017 Agrow Awards. MBI’s products, REGALIA Biofungicide and GRANDEVO Bioinsecticide and MAJESTENE Bionematicide were previous winners in the “Best New Biopesticide” category. Pam Marrone was awarded “Best Manager with Strategic Vision” in 2014.
Winners will be announced at the awards ceremony in London Nov. 12. For more information about the Agrow Awards, visit: https://agrowawards.com/.
About Marrone Bio Innovations
BIO WITH BITE.
Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of over 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® Stargus® and Amplitude™, Zelto® and Zequanox®.
Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers, turf managers and consumers around the globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include the potential of our Agrow Awards nominations to drive sales, provide market projections, and realize the potential benefits of our products. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including weather, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.
Marrone Bio Innovations Contacts:
Pam Marrone, CEO and Founder
Telephone: +1 (530) 750-2800
MBI Investor Relations:
MZ Group – MZ North America
MBI Trade Public Relations: